J A Moss - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J A Moss

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

The American Journal of Pathology|October 20, 1998

Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2AL V Anderson, K Davison, J A Moss, et al.

Neuromuscular Disorders : NMD|February 13, 2001

Strategy for mutation analysis in the autosomal recessive limb-girdle muscular dystrophiesR Pogue, L V Anderson, A Pyle, et al.

Human Molecular Genetics|April 10, 1999

Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s)T Weiler, R Bashir, L V Anderson, et al.

Human Molecular Genetics|April 10, 1999

Dysferlin is a plasma membrane protein and is expressed early in human developmentL V Anderson, K Davison, J A Moss, et al.

The Journal of Antimicrobial Chemotherapy|May 5, 2012

Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ringM J Keller, A M Malone, C A Carpenter, et al.

Neuromuscular Disorders : NMD|October 29, 2000

Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies)L V Anderson, R M Harrison, R Pogue, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

The American Journal of Pathology|October 20, 1998

Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2AL V Anderson, K Davison, J A Moss, et al.

Neuromuscular Disorders : NMD|February 13, 2001

Strategy for mutation analysis in the autosomal recessive limb-girdle muscular dystrophiesR Pogue, L V Anderson, A Pyle, et al.

Human Molecular Genetics|April 10, 1999

Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s)T Weiler, R Bashir, L V Anderson, et al.

Human Molecular Genetics|April 10, 1999

Dysferlin is a plasma membrane protein and is expressed early in human developmentL V Anderson, K Davison, J A Moss, et al.

The Journal of Antimicrobial Chemotherapy|May 5, 2012

Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ringM J Keller, A M Malone, C A Carpenter, et al.

Neuromuscular Disorders : NMD|October 29, 2000

Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies)L V Anderson, R M Harrison, R Pogue, et al.

Pageof 2